Cladribine tablets in the new multiple sclerosis era
Multiple sclerosis (MS) is an autoimmune condition characterized by inflammatory demyelination that leads to irreversible neurological damage within the central nervous system (CNS). This review examines the therapeutic potential and clinical efficacy of cladribine tablets (CladT) for treating MS, f...
| 出版年: | Therapeutic Advances in Neurological Disorders |
|---|---|
| 主要な著者: | Fabio Buttari, Ettore Dolcetti, Francesca Romana Rizzo, Caterina Rizzi, Gianluca Lauritano, Angela Borrelli, Federica Azzolini, Roberta Fantozzi, Francesco Assogna, Antonella Conte, Diego Centonze |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
SAGE Publishing
2025-06-01
|
| オンライン･アクセス: | https://doi.org/10.1177/17562864251342855 |
類似資料
Tumor necrosis factor superfamily in multiple sclerosis: from pathology to therapeutic implications
著者:: Federica Azzolini, 等
出版事項: (2023-05-01)
著者:: Federica Azzolini, 等
出版事項: (2023-05-01)
Physical exercise and synaptic protection in human and pre-clinical models of multiple sclerosis
著者:: Federica Azzolini, 等
出版事項: (2024-01-01)
著者:: Federica Azzolini, 等
出版事項: (2024-01-01)
Cost-Consequences of Cladribine Tablets for the Treatment of Highly Active Relapsing–Remitting Multiple Sclerosis in Italy
著者:: Barbara Polistena, 等
出版事項: (2025-06-01)
著者:: Barbara Polistena, 等
出版事項: (2025-06-01)
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis
著者:: Krizia Sanna, 等
出版事項: (2024-06-01)
著者:: Krizia Sanna, 等
出版事項: (2024-06-01)
Prospective observational study to evaluate treatment satisfaction and effectiveness in patients with relapsing multiple sclerosis starting cladribine tablets (CLADREAL) in Italy
著者:: Massimo Filippi, 等
出版事項: (2024-04-01)
著者:: Massimo Filippi, 等
出版事項: (2024-04-01)
Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis
著者:: Pierre Clavelou, 等
出版事項: (2023-06-01)
著者:: Pierre Clavelou, 等
出版事項: (2023-06-01)
Experience with cladribine tablets for highly active multiple sclerosis in everyday clinical practice
著者:: S. V. Petrov, 等
出版事項: (2020-08-01)
著者:: S. V. Petrov, 等
出版事項: (2020-08-01)
Experience with cladribine tablets for highly active multiple sclerosis in real clinical practice
著者:: S. V. Petrov, 等
出版事項: (2022-02-01)
著者:: S. V. Petrov, 等
出版事項: (2022-02-01)
Recommendations for the use of cladribine tablets for the pathogenetic treatment of patients with highly active multiple sclerosis
著者:: K. Z. Bakhtiyarova, 等
出版事項: (2020-06-01)
著者:: K. Z. Bakhtiyarova, 等
出版事項: (2020-06-01)
Treatment of Multiple Sclerosis with Cladribine Tablets: Literature Review and the Guidance of the Lithuanian Association of Neurologists
著者:: R. Kizlaitienė, 等
出版事項: (2024-03-01)
著者:: R. Kizlaitienė, 等
出版事項: (2024-03-01)
Correction: Expert Narrative Review of the Safety of Cladribine Tablets for the Management of Relapsing Multiple Sclerosis
著者:: Pierre Clavelou, 等
出版事項: (2023-11-01)
著者:: Pierre Clavelou, 等
出版事項: (2023-11-01)
Treatment of Multiple Sclerosis with Cladribine Tablets: Literature Review and the Guidance of the Lithuanian Association of Neurologists
著者:: R. Kizlaitienė, 等
出版事項: (2024-03-01)
著者:: R. Kizlaitienė, 等
出版事項: (2024-03-01)
Low-contrast visual acuity test is associated with central inflammation and predicts disability development in newly diagnosed multiple sclerosis patients
著者:: Ettore Dolcetti, 等
出版事項: (2024-02-01)
著者:: Ettore Dolcetti, 等
出版事項: (2024-02-01)
Inflammatory signature in amyotrophic lateral sclerosis predicting disease progression
著者:: Cinzia Femiano, 等
出版事項: (2024-08-01)
著者:: Cinzia Femiano, 等
出版事項: (2024-08-01)
Role of Immune Reconstitution Therapy with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in Older Patients
著者:: Raed Alroughani, 等
出版事項: (2025-05-01)
著者:: Raed Alroughani, 等
出版事項: (2025-05-01)
Narrative Review on the Use of Cladribine Tablets as Exit Therapy for Stable Elderly Patients with Multiple Sclerosis
著者:: Jerome de Seze, 等
出版事項: (2024-04-01)
著者:: Jerome de Seze, 等
出版事項: (2024-04-01)
Experience of cladribine tablets usage in the treatment of multiple sclerosis in the Multiple Sclerosis Centre of the Khanty-Mansi Autonomous Area — Yugra
著者:: A. A. Sokolova, 等
出版事項: (2024-06-01)
著者:: A. A. Sokolova, 等
出版事項: (2024-06-01)
Efficacy of Cladribine Tablets as a Treatment for People With Multiple Sclerosis: Protocol for the CLOBAS Study (Cladribine, a Multicenter, Long-term Efficacy and Biomarker Australian Study)
著者:: Vicki E Maltby, 等
出版事項: (2021-10-01)
著者:: Vicki E Maltby, 等
出版事項: (2021-10-01)
Performing a physiologically relevant test for cladribine tablets
著者:: P. A. Losenkova, 等
出版事項: (2024-09-01)
著者:: P. A. Losenkova, 等
出版事項: (2024-09-01)
Osteopontin Is Associated with Multiple Sclerosis Relapses
著者:: Mario Stampanoni Bassi, 等
出版事項: (2023-01-01)
著者:: Mario Stampanoni Bassi, 等
出版事項: (2023-01-01)
Recommendations for switching patients with highly active multiple sclerosis from other disease modifying drugs for multiple sclerosis to cladribine tablets
著者:: N. A. Totolyan, 等
出版事項: (2020-10-01)
著者:: N. A. Totolyan, 等
出版事項: (2020-10-01)
Identifying Cladribine prescription pattern in MS: an Italian multicentre study
著者:: Aurora Zanghì, 等
出版事項: (2025-01-01)
著者:: Aurora Zanghì, 等
出版事項: (2025-01-01)
Interleukin-10 contrasts inflammatory synaptopathy and central neurodegenerative damage in multiple sclerosis
著者:: Luana Gilio, 等
出版事項: (2024-08-01)
著者:: Luana Gilio, 等
出版事項: (2024-08-01)
Effect of Cladribine Tablets on the Pharmacokinetics of a Combined Oral Contraceptive in Pre‐Menopausal Women With Relapsing Multiple Sclerosis
著者:: Robert Hermann, 等
出版事項: (2025-04-01)
著者:: Robert Hermann, 等
出版事項: (2025-04-01)
Holistic, Long-Term Management of People with Relapsing Multiple Sclerosis with Cladribine Tablets: Expert Opinion from France
著者:: Jonathan Ciron, 等
出版事項: (2024-03-01)
著者:: Jonathan Ciron, 等
出版事項: (2024-03-01)
Cladribine Tablets and Relapsing–Remitting Multiple Sclerosis: A Pragmatic, Narrative Review of What Physicians Need to Know
著者:: Mohamed AlJumah, 等
出版事項: (2020-02-01)
著者:: Mohamed AlJumah, 等
出版事項: (2020-02-01)
Cladribine tablets after treatment with natalizumab (CLADRINA) – rationale and design
著者:: Peter V. Sguigna, 等
出版事項: (2024-04-01)
著者:: Peter V. Sguigna, 等
出版事項: (2024-04-01)
Assessment of the impact of reconstitution therapies—cladribine tablets and alemtuzumab—on the atrophy progression among patients with relapse-remitting multiple sclerosis
著者:: Aleksandra Pogoda-Wesołowska, 等
出版事項: (2025-02-01)
著者:: Aleksandra Pogoda-Wesołowska, 等
出版事項: (2025-02-01)
Multicentre Observational Study of Treatment Satisfaction with Cladribine Tablets in the Management of Relapsing Multiple Sclerosis in the Arabian Gulf: The CLUE Study
著者:: Jihad Inshasi, 等
出版事項: (2023-06-01)
著者:: Jihad Inshasi, 等
出版事項: (2023-06-01)
Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study
著者:: Heinz Wiendl, 等
出版事項: (2025-02-01)
著者:: Heinz Wiendl, 等
出版事項: (2025-02-01)
Fatigue in Multiple Sclerosis Is Associated with Reduced Expression of Interleukin-10 and Worse Prospective Disease Activity
著者:: Luana Gilio, 等
出版事項: (2022-08-01)
著者:: Luana Gilio, 等
出版事項: (2022-08-01)
Neuroinflammation Is Associated with GFAP and sTREM2 Levels in Multiple Sclerosis
著者:: Federica Azzolini, 等
出版事項: (2022-01-01)
著者:: Federica Azzolini, 等
出版事項: (2022-01-01)
Corrigendum: Blood biomarker dynamics in people with relapsing multiple sclerosis treated with cladribine tablets: results of the 2-year MAGNIFY-MS study
著者:: Heinz Wiendl, 等
出版事項: (2025-03-01)
著者:: Heinz Wiendl, 等
出版事項: (2025-03-01)
The gut-brain-axis one year after treatment with cladribine tablets in patients with relapsing remitting multiple sclerosis: a pilot study
著者:: Jeske van Pamelen, 等
出版事項: (2025-02-01)
著者:: Jeske van Pamelen, 等
出版事項: (2025-02-01)
Making Information About Cladribine Tablets Accessible to People with Multiple Sclerosis: A Patient-Survey-Led Narrative Review for Healthcare Professionals
著者:: Ardra Shephard, 等
出版事項: (2024-05-01)
著者:: Ardra Shephard, 等
出版事項: (2024-05-01)
Real-Life Experience of the Effects of Cladribine Tablets on Lymphocyte Subsets and Serum Neurofilament Light Chain Levels in Relapsing Multiple Sclerosis Patients
著者:: Damiano Paolicelli, 等
出版事項: (2022-11-01)
著者:: Damiano Paolicelli, 等
出版事項: (2022-11-01)
Molecular signature associated with cladribine treatment in patients with multiple sclerosis
著者:: Nicolas Fissolo, 等
出版事項: (2023-07-01)
著者:: Nicolas Fissolo, 等
出版事項: (2023-07-01)
Summary of Research: Blood Biomarker Dynamics in People with Relapsing Multiple Sclerosis Treated with Cladribine Tablets: Results of the 2-Year MAGNIFY-MS Study
著者:: Heinz Wiendl, 等
出版事項: (2025-07-01)
著者:: Heinz Wiendl, 等
出版事項: (2025-07-01)
Long-term impact of oral cladribine on humoral immunity in multiple sclerosis
著者:: Marc Messner, 等
出版事項: (2025-08-01)
著者:: Marc Messner, 等
出版事項: (2025-08-01)
Prolonged observation after the use of cladribine in multiple sclerosis: efficacy and safety
著者:: A. D. Kukushkina, 等
出版事項: (2023-08-01)
著者:: A. D. Kukushkina, 等
出版事項: (2023-08-01)
類似資料
-
Tumor necrosis factor superfamily in multiple sclerosis: from pathology to therapeutic implications
著者:: Federica Azzolini, 等
出版事項: (2023-05-01) -
Physical exercise and synaptic protection in human and pre-clinical models of multiple sclerosis
著者:: Federica Azzolini, 等
出版事項: (2024-01-01) -
Cost-Consequences of Cladribine Tablets for the Treatment of Highly Active Relapsing–Remitting Multiple Sclerosis in Italy
著者:: Barbara Polistena, 等
出版事項: (2025-06-01) -
Re-emergence of T lymphocyte-mediated synaptopathy in progressive multiple sclerosis
著者:: Krizia Sanna, 等
出版事項: (2024-06-01) -
Prospective observational study to evaluate treatment satisfaction and effectiveness in patients with relapsing multiple sclerosis starting cladribine tablets (CLADREAL) in Italy
著者:: Massimo Filippi, 等
出版事項: (2024-04-01)